TradingView
MarketMoversReport
Aug 25, 2022 4:44 PM
Clover Announces Positive Phase 2/3 Results in Adolescents
Long
NASDAQ:DVAX
1D
Dynavax Technologies Corporation
NASDAQ
Description
⋅
Aug 25, 2022 4:44 PM
DVAX: Clover Biopharmaceuticals
2022-08-25 06:23:27 Clover Announces Positive Phase 2/3 Results in Adolescents for its COVID-19 Vaccine
Beyond Technical Analysis
More